Marathon Oil Corp. (NYSE:MRO) had its price target cut by Argus from $47.00 to $35.00 in a research report sent to investors on Tuesday morning. The firm currently has a buy rating on the stock. Marathon Oil Corporation (NYSE:MRO) in last trading activity fell -1.50% to close at $26.86. Company weekly performance is -6.02% while its quarterly performance stands at -26.19%. Marathon Oil Corporation (NYSE:MRO) is -35.50% away from its 52 week high.
The Chief Scientific Officer, of Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Palombella Vito J. had unloaded 4,737 shares at $16.32 per share in a transaction on December 15, 2014. The total value of transaction was $77,308. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing. On last trading day Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) fell -3.71% to close at $16.08. Its volatility for the week is 4.98% while volatility for the month is 5.94%. INFI’s EPS growth for past 5 years was -33.80%. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) monthly performance is 1.84%.
Preferred Bank (NASDAQ:PFBC) declared a quarterly dividend on Friday, December 19th. Shareholders of record on Tuesday, January 6th will be given a dividend of 0.10 per share on Tuesday, January 20th. This represents a $0.40 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, January 2nd. Preferred Bank (NASDAQ:PFBC) has 9.18% insider ownership while its institutional ownership stands at 54.00%. In last trading activity company’s stock closed at $25.63.
Twitter Inc. (NYSE:TWTR) CEO Richard Costolo sold 140,352 shares of Twitter stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $36.31, for a total transaction of $5,096,181.12. Following the completion of the transaction, the chief executive officer now directly owns 818,608 shares of the company’s stock, valued at approximately $29,723,656. Twitter Inc (NYSE:TWTR) in last trading activity moved up 6.54% to close at $38.76. Company weekly performance is 6.43% while its quarterly performance stands at -27.54%. Twitter Inc (NYSE:TWTR) is -42.77% away from its 52 week high.
NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas. Attendees will get their first glimpse of Quell at Booth # 73311 in the Digital Health section of CES. NeuroMetrix will also be one of an exclusive group that will participate in CES Unveiled, the official press event of CES. On last trading day NeuroMetrix Inc. (NASDAQ:NURO) fell -4.28% to close at $1.79. Its volatility for the week is 9.29% while volatility for the month is 6.22%. NURO’s sales growth for past 5 years was -29.80% and its EPS growth for past 5 years was 43.90%. NeuroMetrix Inc. (NASDAQ:NURO) monthly performance is 2.87%.